Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
390.00    -1.00 (-0.26%)
Bid:
390.00
Ask:
392.00
Spread: 2.00 (0.513%)
Market Cap: £498.18m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Interim Management Statement

15 Dec 2010 15:45

RNS Number : 0395Y
North Atlantic Smlr Co Inv Tst PLC
15 December 2010
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2010

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

 

Cumulative performance

As at

31 October 2010

months %

6 months %

1 year

%

3 years

%

5 years

%

NAV *

Basic

1,552p 

2.1 

4.5 

12.6

(11.5)

2.6

Diluted

1,364p 

2.2 

13.9 

25.1

3.9 

36.7

Mid-market price

1,045.0p 

7.2 

14.1 

33.7

(12.6)

10.0

Discount to diluted NAV *

23.4% 

Standard & Poor's 500 Composite Index **

737.8

5.1 

(5.0)

17.2

(1.0)

8.1

Russell 2000 **

438.6

5.7 

(6.5)

28.2

10.2 

20.0

FTSE All-Share Index

2,936.2

8.1 

2.5 

13.6

(15.0)

10.2

US Dollar/Sterling exchange rate

1.5988

(2.1)

(4.5)

3.0

23.0 

9.7

 

* Excluding retained revenue for the period.

** Sterling adjusted.

 

Material Events and Transactions during the Period

 

Transaction in Own Shares

 

On 13 September 2010 the Company announced that it had purchased 35,000 Ordinary shares of 5p each for cancellation representing approximately 0.24% of the issued share capital at a price of 965p per share. In addition the Company purchased 25,000 units of Convertible Unsecured Loan Stock 2013 ("CULS") at a price of 965p per unit for cancellation leaving 1,970,800 units outstanding.

 

On 10 December 2010 the Company announced that it had purchased 200,000 Ordinary shares of 5p each for cancellation representing approximately 1.4% of the issued share capital at a price of 1005p per share.

 

Following the above transactions the Company's issued share capital now consists of 14,057,252 ordinary shares with voting rights and there are 1,970,800 CULS units outstanding.

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2010

 

US Treasury Bills

US T Bills

13.06

Oryx International Growth Fund Limited *

UK Listed

9.66

RPC Group

UK Listed

6.46

BBA Aviation Group Plc

UK Listed

6.35

Nationwide Accident Repair Services Plc

UK Quoted on AIM

5.35

Bionostics Holdings Ltd

USA Unquoted

5.34

Bionostics Holdings Ltd Preference Shares

USA Unquoted

4.69

Trident Private Equity Fund III LP

UK Unquoted

3.95

Gleeson (M.J.) Group Plc

UK Listed

3.77

Hampton New

UK Unquoted

3.58

% of total portfolio

62.21

* Incorporated in Guernsey

 

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2010

 

 

United 

United 

States 

Kingdom 

Europe 

Total 

Investment Companies

0.6

18.6

19.2

Treasury Bills

13.1

13.1

Manufacturing

10.0

0.6

10.6

Real Estate

7.9

1.1

9.0

Support Services

1.4

7.4

8.8

General Industrials

1.8

6.5

8.3

Health Care, Equipment & Services

4.0

3.9

7.9

Industrial Transportation

6.3

6.3

Industrial Engineering

4.1

4.1

Construction & Materials

3.8

3.8

Media

3.2

3.2

Technology Hardware & Equipment

1.5

1.0

2.5

General Financials

1.0

0.1

1.1

Travel & Leisure

1.0

1.0

Oil & Gas Producers

0.9

0.9

Food Producers

0.2

0.2

Total at 31 October 2010

33.4

65.5

1.1

100.0

Total at 31 January 2010

11.3

85.3

3.4

 

The financial information for the period ended 31 October 2010 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

Mark Purnell for and on behalf of

J O Hambro Capital Management Limited as Company Secretary

 

15 December 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMMZKKKGGZM
Date   Source Headline
6th Aug 20259:57 amRNSTransaction in Own Shares and TVR
15th Jul 20259:34 amRNSNet Asset Value(s)
7th Jul 20251:00 pmRNSTransaction in Own Shares and TVR
7th Jul 202511:34 amRNSTransaction in Own Shares and TVR
19th Jun 20259:51 amRNSTransaction in Own Shares nad TVR
13th Jun 20253:52 pmRNSNet Asset Value(s)
12th Jun 20251:50 pmRNSShare Split and Total Voting Rights
12th Jun 20251:46 pmRNSResult of AGM
9th Jun 202510:45 amRNSTransaction in Own Shares and TVR
2nd Jun 20251:15 pmRNSTransaction in Own Shares and TVR
30th May 202511:01 amRNSTransaction in Own Shares and TVR
27th May 20253:26 pmRNSTransaction in Own Shares and TVR
23rd May 20251:44 pmRNSCompany Secretary Change
16th May 20257:00 amRNSNet Asset Value(s)
15th May 20257:00 amRNSAnnual Financial Report & Notice of AGM
7th May 20257:00 amRNSFinal Results
16th Apr 20257:00 amRNSNet Asset Value(s)
3rd Apr 202510:35 amRNSTransaction in Own Shares and TVR
31st Mar 20259:44 amRNSTransaction in Own Shares and TVR
24th Mar 20259:13 amRNSTransaction in Own Shares and TVR
18th Mar 20253:15 pmRNSNet Asset Value(s)
3rd Mar 20252:17 pmRNSTransaction in Own Shares and TVR
27th Feb 20257:00 amRNSDividend Declaration
17th Feb 202512:49 pmRNSTransaction in Own Shares and TVR
14th Feb 20259:26 amRNSNet Asset Value(s)
10th Feb 202511:05 amRNSTransaction in Own Shares and TVR
15th Jan 202511:10 amRNSDirector Declaration
15th Jan 202511:01 amRNSDirector Declaration
15th Jan 202510:39 amRNSNet Asset Value(s)
12th Dec 20241:48 pmRNSNet Asset Value(s)
29th Nov 202411:57 amRNSTransaction in Own Shares
25th Nov 202410:10 amRNSTransaction in Own Shares
15th Nov 202410:57 amRNSNet Asset Value(s)
11th Nov 202410:30 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 202411:50 amRNSNet Asset Value(s)
28th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 202411:51 amRNSInvestment Update: Performance Chemicals
3rd Oct 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSHalf-year Report - Replacement
25th Sep 20247:00 amRNSHalf-year Report
13th Sep 20247:00 amRNSNet Asset Value(s)
14th Aug 202410:40 amRNSNet Asset Value(s)
26th Jul 202410:20 amRNSTransaction in Own Shares
25th Jul 202411:08 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20243:35 pmRNSTransaction in Own Shares
11th Jul 20247:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.